Laboratory Medicine ›› 2025, Vol. 40 ›› Issue (10): 1025-1029.DOI: 10.3969/j.issn.1673-8640.2025.10.017
Previous Articles Next Articles
Received:2024-09-22
Revised:2025-03-06
Online:2025-10-30
Published:2025-11-07
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2025.10.017
| [1] |
POLLYEA D A, ALTMAN J K, ASSI R, et al. Acute myeloid leukemia,version 3.2023,NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2023, 21(5):503-513.
DOI URL |
| [2] |
SCHUH A C. Timely diagnosis and treatment of acute promyelocytic leukemia should be available to all[J]. Haematologica, 2022, 107(3):570-571.
DOI URL |
| [3] |
NI X, HU G, CAI X. The success and the challenge of all-trans retinoic acid in the treatment of cancer[J]. Crit Rev Food Sci Nutr, 2019, 59(1):S71-S80.
DOI URL |
| [4] |
MA Y F, LU Y, WU Q, et al. Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia[J]. J Hematol Oncol, 2022, 15(1): 148.
DOI |
| [5] |
MCDONNELL M H, SMITH E T Jr, LIPFORD E H, et al. Microgranular acute promyelocytic leukemia presenting with leukopenia and an unusual immunophenotype[J]. Hematol Oncol Stem Cell Ther, 2017, 10(1):35-38.
DOI PMID |
| [6] | KRISHNAMURTHY K, CHOUDHURI J, RAMESH K H, et al. MPO expression of background neutrophils in mpo negative acute promyelocytic leukemia,an easy clue to corroborate a challenging diagnosis:a case report and review of literature[J]. Case Rep Hematol, 2023, 2023:7979261. |
| [7] |
MO X, CHEN H. Acute promyelocytic leukaemia with myeloperoxidase-negative rectangular inclusions[J]. Br J Haematol, 2020, 188(1):8.
DOI URL |
| [8] | GLEGHORN D M, THOMAS W. Prevalence of myeloperoxidase deficiency determined using an ADVIA 2120i[J]. Int J Lab Hematol, 2020, 42(5):e220-e223. |
| [9] |
HEIBLIG M, PAUBELLE E, PLESA A, et al. Comprehensive analysis of a myeloperoxidase-negative acute promyelocytic leukemia[J]. Blood, 2017, 129(1):128-131.
DOI PMID |
| [10] |
ROMANI C, MURRU R, PETTINAU M, et al. A case of fatal overwhelming microgranular variant(M3v)of acute promyelocytic leukemia with extensive extramedullary involvement[J]. Int J Hematol, 2010, 91(3):551-552.
DOI URL |
| [11] |
ZHANG X, SUN J, YU W, et al. Current views on the genetic landscape and management of variant acute promyelocytic leukemia[J]. Biomark Res, 2021, 9(1):33.
DOI PMID |
| [12] |
ZHANG X W, YAN X J, ZHOU Z R, et al. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML[J]. Science, 2010, 328(5975):240-243.
DOI URL |
| [13] |
KOZONO S, LIN Y M, SEO H S, et al. Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells[J]. Nat Commun, 2018, 9(1):3069.
DOI PMID |
| [14] |
LI Y, MA X, CHEN Z, et al. B1 oligomerization regulates PML nuclear body biogenesis and leukemogenesis[J]. Nat Commun, 2019, 10(1):3789.
DOI PMID |
| [15] |
LI Y, MA X, WU W, et al. PML nuclear body biogenesis,carcinogenesis,and targeted therapy[J]. Trends Cancer, 2020, 6(10):889-906.
DOI URL |
| [16] |
LI Y, MA X, MENG G. PML nuclear body biogenesis and oligomerization-driven leukemogenesis[J]. Blood Sci, 2020, 2(1):7-10.
DOI PMID |
| [17] | LALLEMAND-BREITENBACH V, DE THÉ H. PML nuclear bodies[J]. Cold Spring Harb Perspect Biol, 2010, 2(5):a000661. |
| [18] |
WANG P, BENHENDA S, WU H, et al. RING tetramerization is required for nuclear body biogenesis and PML sumoylation[J]. Nat Commun, 2018, 9(1):1277.
DOI PMID |
| [19] |
VERMA S, SINGHAL P, SINGH S, et al. Atypical morphology and aberrant immunophenotypic expression:a diagnostic dilemma in acute promyelocytic leukemia[J]. J Appl Hematol, 2022, 13(1):63-67.
DOI URL |
| [20] |
FANG H, WANG S A, HU S, et al. Acute promyelocytic leukemia:immunophenotype and differential diagnosis by flow cytometry[J]. Cytometry B Clin Cytom, 2022, 102(4):283-291.
DOI URL |
| [1] | LIU Min, SUN Hengjuan, DU Chengkan, XIA Min, JIANG Linlin, WENG Wenhao, ZHANG Hong. Laboratory analysis of 6 cases of acute megakaryocytic leukemia in children [J]. Laboratory Medicine, 2025, 40(5): 484-488. |
| [2] | LIU Mengna, WANG Hongling, BAI Ping, CAI Yu, LI Li. Research progress on laboratory diagnosis and treatment of ETP-ALL [J]. Laboratory Medicine, 2025, 40(1): 1-7. |
| [3] | DING Jing, ZHANG Chunling, WANG Xiaorui, LI Huidan, WANG Hongling, LIU Weiling, LIN Lihui, LI Li. Laboratory diagnosis and prognostic factor analysis of core binding factor-related acute myeloid leukemia [J]. Laboratory Medicine, 2024, 39(7): 673-681. |
| [4] | CHEN Yongwei, WANG Jing, YANG Xiaolong, HU Fangyu, LIN Fang. Applicability of CLSI EP09-A3 in 2-method comparison determining serum total triiodothyronine [J]. Laboratory Medicine, 2024, 39(2): 176-180. |
| [5] | . [J]. Laboratory Medicine, 2024, 39(1): 100-102. |
| [6] | . [J]. Laboratory Medicine, 2021, 36(12): 1292-1294. |
| [7] | . [J]. , 2007, 22(05): 574-577. |
| [8] | . [J]. , 2007, 22(02): 213-214. |
| [9] | . [J]. , 2006, 21(05): 533-536. |
| [10] | . [J]. , 2006, 21(04): 438-439. |
| [11] | . [J]. , 2006, 21(03): 254-258. |
| [12] | ZHANG Qiutang;LI Tao. Immunophenotyping of 201 adult patients with acute leukemia [J]. , 2005, 20(04): 373-375. |
| [13] | WU Jianguo;WU Mao;QIU Liannü;LIN Huijun;CHEN Zhimei;WANG Yungui. Report of a case of acute myeloid leukemia characterized by double t (8; 21 ) translocations [J]. , 2005, 20(02): 104-108. |
| [14] | . Study on the expression of ki-67 in acute leukemia [J]. , 2004, 19(06): 544-545. |
| [15] | . The expression and clinical significance of c-myc gene in bone marrow of acute myelogenous leukemia [J]. , 2000, 15(06): 329-330. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
